BR plus Zweitgenerations-BTKi in der Erstlinie bei Älteren mit MCL effektiv

Im Focus Onkologie 2026

View at publisher
Authors: Sabrina Kempe
DOI: 10.1007/s15015-026-4499-8
Cited by: 0

Fields of Study & Subjects

Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research Cutaneous lymphoproliferative disorders research

Publication details

Journal / source
Im Focus Onkologie
Volume
29
Issue
1-2
Pages
46–46
Publication date
1 February 2026
Language
DE